Investment giant sees Sigma upside


Global broker Morgan Stanley began coverage of Sigma Healthcare, indicating it sees room to grow for the newly merged company Sigma’s share price shot up by almost 3% in Friday’s trade after the financial services giant initiated its coverage of the stock. Morgan Stanley rated Sigma “overweight” and a price target of $3.45. On Friday,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Aged care champion honoured
Next The role of community pharmacy has never been more vital in our health system